| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
|
Nat Genet
|
2010
|
17.38
|
|
2
|
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
|
Nat Genet
|
2011
|
7.98
|
|
3
|
Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study.
|
Gastrointest Endosc
|
2011
|
2.96
|
|
4
|
Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.
|
Am J Gastroenterol
|
2009
|
2.53
|
|
5
|
Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening.
|
J Crohns Colitis
|
2012
|
2.21
|
|
6
|
Use of acid-suppressing drugs and the risk of bacterial gastroenteritis.
|
Clin Gastroenterol Hepatol
|
2007
|
1.95
|
|
7
|
Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.
|
Inflamm Bowel Dis
|
2010
|
1.91
|
|
8
|
Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.
|
Gastroenterology
|
2006
|
1.71
|
|
9
|
Life events and inflammatory bowel disease relapse: a prospective study of patients enrolled in remission.
|
Am J Gastroenterol
|
2006
|
1.71
|
|
10
|
Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.
|
Gut
|
2012
|
1.68
|
|
11
|
Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats.
|
J Cereb Blood Flow Metab
|
2003
|
1.55
|
|
12
|
Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study.
|
Gut
|
2012
|
1.43
|
|
13
|
Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence.
|
Ann Surg
|
2005
|
1.33
|
|
14
|
Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.
|
J Leukoc Biol
|
2004
|
1.28
|
|
15
|
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
|
Am J Gastroenterol
|
2009
|
1.23
|
|
16
|
Optimising monitoring in the management of Crohn's disease: a physician's perspective.
|
J Crohns Colitis
|
2013
|
1.20
|
|
17
|
Relative roles of ICAM-1 and VCAM-1 in the pathogenesis of experimental radiation-induced intestinal inflammation.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.19
|
|
18
|
Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea.
|
Respir Physiol Neurobiol
|
2006
|
1.15
|
|
19
|
Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice.
|
J Cereb Blood Flow Metab
|
2006
|
1.08
|
|
20
|
Direct evidence of leukocyte adhesion in arterioles by angiotensin II.
|
Blood
|
2004
|
1.08
|
|
21
|
Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities.
|
Clin Gastroenterol Hepatol
|
2007
|
1.00
|
|
22
|
The role of P-selectin in experimental colitis as determined by antibody immunoblockade and genetically deficient mice.
|
J Leukoc Biol
|
2002
|
1.00
|
|
23
|
Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease.
|
J Crohns Colitis
|
2011
|
0.99
|
|
24
|
Defective IL-10 production in severe phenotypes of Crohn's disease.
|
J Leukoc Biol
|
2009
|
0.99
|
|
25
|
Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality.
|
Inflamm Bowel Dis
|
2008
|
0.94
|
|
26
|
Imaging indexes of activity and severity for Crohn's disease: current status and future trends.
|
Abdom Imaging
|
2012
|
0.92
|
|
27
|
Effect of cyclosporin A on cell adhesion molecules and leukocyte-endothelial cell interactions in experimental colitis.
|
Inflamm Bowel Dis
|
2004
|
0.91
|
|
28
|
A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300.
|
Gut
|
2012
|
0.90
|
|
29
|
Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome.
|
J Crohns Colitis
|
2012
|
0.90
|
|
30
|
Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease.
|
Radiographics
|
2009
|
0.89
|
|
31
|
Down-regulation of endothelial adhesion molecules and leukocyte adhesion by treatment with superoxide dismutase is beneficial in chronic immune experimental colitis.
|
Inflamm Bowel Dis
|
2005
|
0.89
|
|
32
|
Risk factors and characteristics of extent progression in ulcerative colitis.
|
Inflamm Bowel Dis
|
2009
|
0.87
|
|
33
|
Anti-inflammatory effects of low-dose radiotherapy in an experimental model of systemic inflammation in mice.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.86
|
|
34
|
Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey.
|
BMC Gastroenterol
|
2012
|
0.86
|
|
35
|
Clinical implications of COX-1 and/or COX-2 inhibition for the distal gastrointestinal tract.
|
Curr Pharm Des
|
2003
|
0.86
|
|
36
|
Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase.
|
PLoS One
|
2011
|
0.86
|
|
37
|
Evaluation of responsive gene expression as a sensitive and specific biomarker in patients with ulcerative colitis.
|
Inflamm Bowel Dis
|
2013
|
0.82
|
|
38
|
Steroid-refractory ulcerative colitis: predictive factors of response to cyclosporine and validation in an independent cohort.
|
Inflamm Bowel Dis
|
2008
|
0.81
|
|
39
|
Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice.
|
Lab Invest
|
2002
|
0.81
|
|
40
|
Trefoil peptide TFF2 treatment reduces VCAM-1 expression and leukocyte recruitment in experimental intestinal inflammation.
|
J Leukoc Biol
|
2003
|
0.81
|
|
41
|
Fructose-1,6-biphosphate and nucleoside pool modifications prevent neutrophil accumulation in the reperfused intestine.
|
J Leukoc Biol
|
2003
|
0.81
|
|
42
|
Protective effect of superoxide dismutase in radiation-induced intestinal inflammation.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.80
|
|
43
|
Time course of anti-inflammatory effect of low-dose radiotherapy: correlation with TGF-beta(1) expression.
|
Radiother Oncol
|
2007
|
0.80
|
|
44
|
Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cells.
|
PLoS One
|
2012
|
0.80
|
|
45
|
National differences in ulcerative colitis experience and management among patients from five European countries and Canada: an online survey.
|
J Crohns Colitis
|
2012
|
0.80
|
|
46
|
[Dendritic cells: a new horizon in cell therapy for inflammatory bowel disease?].
|
Gastroenterol Hepatol
|
2011
|
0.79
|
|
47
|
Leukocyte recruitment in colon cancer: role of cell adhesion molecules, nitric oxide, and transforming growth factor beta1.
|
Gastroenterology
|
2002
|
0.79
|
|
48
|
Cell therapies for IBD: what works?
|
Curr Drug Targets
|
2013
|
0.79
|
|
49
|
Cell therapies for inflammatory bowel diseases.
|
Expert Rev Gastroenterol Hepatol
|
2009
|
0.79
|
|
50
|
Corrigendum: Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.
|
Am J Gastroenterol
|
2015
|
0.78
|
|
51
|
[The Hirsch's h-index: a new tool for measuring scientific production].
|
Cir Esp
|
2009
|
0.78
|
|
52
|
Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis.
|
Am J Physiol Gastrointest Liver Physiol
|
2006
|
0.78
|
|
53
|
Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease.
|
Gastroenterol Hepatol
|
2010
|
0.77
|
|
54
|
Are we giving biologics too late? The case for early versus late use.
|
World J Gastroenterol
|
2008
|
0.77
|
|
55
|
[The impact of anxiety and depression on relapse in patients with inflammatory bowel disease].
|
Med Clin (Barc)
|
2009
|
0.77
|
|
56
|
Rituximab in active ulcerative colitis.
|
Gastroenterology
|
2011
|
0.77
|
|
57
|
Idiopathic myelofibrosis associated with ulcerative colitis.
|
Leuk Lymphoma
|
2002
|
0.76
|
|
58
|
Psychometric properties of the original Inflammatory Bowel Disease Questionnaire, a Spanish version.
|
Gastroenterol Hepatol
|
2007
|
0.76
|
|
59
|
What is Disease Progression in Crohn's Disease and how can it be Measured?
|
J Crohns Colitis
|
2015
|
0.76
|
|
60
|
Colonic Crohn's disease: value of magnetic resonance colonography for detection and quantification of disease activity.
|
Abdom Imaging
|
2009
|
0.76
|
|
61
|
Anti-TNF antibody therapy in Crohn's disease: the risk of a switch.
|
Gut
|
2011
|
0.76
|
|
62
|
Toward a safer use of thiopurines in inflammatory bowel disease.
|
Gastroenterology
|
2010
|
0.75
|
|
63
|
Confocal endomicroscopy in celiac disease.
|
Gastroenterology
|
2011
|
0.75
|
|
64
|
Adalimumab in ulcerative colitis: can pharmacodynamics be improved based on pharmacokinetics?
|
Gastroenterology
|
2011
|
0.75
|
|
65
|
Defects in autophagy induce alterations in the secretory pathway and proinflammatory signaling of paneth cells.
|
Gastroenterology
|
2009
|
0.75
|
|
66
|
New imaging standards for evaluation of inflammatory bowel disease?
|
Gastroenterology
|
2012
|
0.75
|
|
67
|
[Iron deficiency anemia and use of intravenous iron in digestive disease].
|
Gastroenterol Hepatol
|
2010
|
0.75
|
|
68
|
Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases.
|
Int J Colorectal Dis
|
2013
|
0.75
|
|
69
|
Inflammatory bowel disease (IBD). Preface.
|
Dig Dis
|
2013
|
0.75
|
|
70
|
Magnetic resonance enterography in Crohn's disease: optimal use in clinical practice and clinical trials.
|
Scand J Gastroenterol
|
2015
|
0.75
|
|
71
|
Safety and activity of dersalazine sodium in patients with mild-to-moderate active colitis: double-blind randomized proof of concept study.
|
Inflamm Bowel Dis
|
2014
|
0.75
|
|
72
|
Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
73
|
Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
|
Am J Gastroenterol
|
2016
|
0.75
|
|
74
|
[Rationale for cell therapy in the treatment of inflammatory bowel disease].
|
Gastroenterol Hepatol
|
2010
|
0.75
|
|
75
|
Lessons to learn from Crohn's disease clinical trials: implications for ulcerative colitis.
|
Curr Drug Targets
|
2011
|
0.75
|
|
76
|
MRI of Crohn's disease: from imaging to pathology.
|
Abdom Imaging
|
2012
|
0.75
|
|
77
|
[Scientific publication, bibliometric indicators, and Hirsch's h-index].
|
Gastroenterol Hepatol
|
2009
|
0.75
|